Lim Wei Yao, Ramasamy Anantharaman, Lloyd Guy, Bhattacharyya Sanjeev
Echocardiography Laboratory, Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Valvular Heart Disease Clinic, Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Heart. 2017 Feb 15;103(4):268-272. doi: 10.1136/heartjnl-2016-309830. Epub 2016 Aug 18.
The management of patients with asymptomatic, severe aortic stenosis (AS) is controversial. We performed a meta-analysis to examine the impact on outcomes of aortic valve replacement (AVR) in patients with severe asymptomatic AS versus a symptom-driven intervention approach.
A search for studies that examined the outcomes of AVR and management of asymptomatic severe AS was performed. We examined the end points of all-cause mortality, cardiac mortality and sudden cardiac death. Our analysis compared early AVR in asymptomatic patients with a symptom-driven AVR approach (excluding symptomatic patients who did not undergo AVR).
Four observational studies were identified with a total of 1300 patients. There was significant heterogeneity between studies (I=72%). Using a random-effects model, there was a trend towards reduced overall mortality in patients undergoing early AVR compared with a symptom-driven AVR approach (OR 0.54, 95% CI 0.26 to 1.12, p=0.1). There was no significant reduction in cardiac mortality or sudden death (OR 0.78, p=0.85, and OR 0.34, p=0.25, respectively).
Although there was a trend towards reduced overall mortality when comparing early AVR in patients with asymptomatic, severe AS to a symptom-driven AVR approach, there was no significant difference in cardiac mortality or sudden death. An individual approach focusing on individual risk stratification and operative mortality is required until more robust, randomised trial data are available.
无症状重度主动脉瓣狭窄(AS)患者的管理存在争议。我们进行了一项荟萃分析,以研究重度无症状AS患者接受主动脉瓣置换术(AVR)与症状驱动干预方法相比对预后的影响。
检索了研究AVR结果及无症状重度AS管理的研究。我们检查了全因死亡率、心脏死亡率和心源性猝死等终点指标。我们的分析比较了无症状患者早期AVR与症状驱动的AVR方法(不包括未接受AVR的有症状患者)。
确定了四项观察性研究,共1300例患者。研究之间存在显著异质性(I=72%)。采用随机效应模型,与症状驱动的AVR方法相比,早期接受AVR的患者总体死亡率有降低趋势(OR 0.54,95%CI 0.26至1.12,p=0.1)。心脏死亡率或猝死率没有显著降低(OR分别为0.78,p=0.85和OR 0.34,p=0.25)。
尽管将无症状重度AS患者早期AVR与症状驱动的AVR方法进行比较时,总体死亡率有降低趋势,但心脏死亡率或猝死率没有显著差异。在获得更有力的随机试验数据之前,需要采取注重个体风险分层和手术死亡率的个体化方法。